BioLife SolutionsBLFS
About: BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Employees: 159
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
14% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 58
7% more capital invested
Capital invested by funds: $1.14B [Q3] → $1.21B (+$76.1M) [Q4]
2.35% more ownership
Funds ownership: 98.53% [Q3] → 100.88% (+2.35%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]
7% less funds holding
Funds holding: 193 [Q3] → 179 (-14) [Q4]
33% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 33
34% less call options, than puts
Call options by funds: $122K | Put options by funds: $184K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
HC Wainwright & Co. Yi Chen 41% 1-year accuracy 67 / 163 met price target | 20%upside $30 | Buy Maintained | 6 Mar 2025 |
Northland Capital Markets Carl Byrnes 83% 1-year accuracy 5 / 6 met price target | 24%upside $31 | Outperform Maintained | 8 Jan 2025 |
Financial journalist opinion
Based on 6 articles about BLFS published over the past 30 days
